Exelixis reported $2.96B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Akebia Therapeutics AKBA:US USD 435.89M 85.91M
Amgen AMGN:US USD 63.7B 4.41B
AstraZeneca AZN:LN USD 94.18B 2.39B
Bayer BAYN:GR EUR 131.01B 2.22B
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Cytokinetics CYTK:US USD 1.08B 304.24M
Eisai 4523:JP JPY 1.26T 11.59B
Eli Lilly And LLY:US USD 47.46B 397.9M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Exelixis EXEL:US USD 2.96B 79.97M
Genmab GEN:DC DKK 30.69B 3.21B
Glaxosmithkline GSK:US GBP 60.31B 28.73B
Immunogen IMGN:US USD 358.8M 63.5M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Macrogenics MGNX:US USD 195.35M 22.7M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Moderna Inc MRNA:US USD 26.06B 13M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Novartis NOVN:VX USD 118.46B 4.45B
Puma Biotechnology PBYI:US USD 198.77M 5.12M
Seattle Genetics SGEN:US USD 3.62B 11.26M
Takeda 4502:JP JPY 14.59T 523.42B
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Xencor XNCR:US USD 835.27M 16.06M
YTE INCY:US USD 5.51B 191.18M